BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2003
View Archived Issues
Company Profile: Transition Therapeutics
Read More
Genzyme to acquire SangStat
Read More
Akina develops oral drug delivery technology
Read More
Two novel series of VR1 antagonists for urinary incontinence, pain, etc.
Read More
Galderma presents new PPARgamma agonists with potential in dermatological disorders
Read More
BMS claims new IMPDH inhibitors and their use in recent patent
Read More
Aventis scientists prepare new antibacterial streptogramin derivatives
Read More
Novel alpha7 nAChR agonists in early development at Bayer
Read More
New MMP, TACE and/or aggrecanase inhibitors covered by BMS patent
Read More
R&D highlights at Neurosearch
Read More
Once-daily Adderall XR formulation may be a useful treatment option in children with ADHD
Read More
FTC clears Biogen/Idec merger
Read More
NexMed enters NexACT R&D agreement for asthma
Read More
Novel 5-HT7 receptor agonist modulates REM sleep
Read More
Human Genome Sciences and Genentech enter licensing agreement
Read More
17-AAG combination regimens studied in new phase Ib trials
Read More
Neurosciences Australia and CSIRO form R&D partnership in brain disorders
Read More
First pivotal exenatide study produces positive results
Read More
MPC-7869 reduces Abeta42 levels more effectively than select NSAIDs
Read More
Exelixis reports quarterly progress
Read More